2011
DOI: 10.3109/10253890.2010.534831
|View full text |Cite
|
Sign up to set email alerts
|

The glucocorticoid contribution to obesity

Abstract: Obesity is fast becoming the scourge of our time. It is one of the biggest causes of death and disease in the industrialized world, and affects as many as 32% of adults and 17% of children in the USA, considered one of the world's fattest nations. It can also cost countries billions of dollars per annum in direct and indirect care, latest estimates putting the USA bill for obesity-related costs at $147 billion in 2008. It is becoming clear that the pathophysiology of obesity is vastly more complicated than the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
97
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 117 publications
(104 citation statements)
references
References 201 publications
6
97
1
Order By: Relevance
“…Moreover, it may induce the expression of proinflammatory genes, favoring macrophage infiltration and providing the environmental conditions for inflammation (57). GC exposure also stimulates LPL activity, whereas it may have an antilipolytic effect, which favors lipid mobilization and TG accumulation (22,94,105). Finally, dexamethasone exposure affects the circadian expression of clock genes in WAT explant cultures (46).…”
Section: Circulating Factorsmentioning
confidence: 99%
“…Moreover, it may induce the expression of proinflammatory genes, favoring macrophage infiltration and providing the environmental conditions for inflammation (57). GC exposure also stimulates LPL activity, whereas it may have an antilipolytic effect, which favors lipid mobilization and TG accumulation (22,94,105). Finally, dexamethasone exposure affects the circadian expression of clock genes in WAT explant cultures (46).…”
Section: Circulating Factorsmentioning
confidence: 99%
“…At the same time, increased food intake and b o d y w e i g h t g a i n h a v e b e e n o b s e r v e d i n humans following glucocorticoid treatment (Tataranni et al, 1996). Stress conditions, characterized by elevated circulating glucocorticoids levels, are also associated with increased food intake, body weight gain and obesity (Dallman et al, 2003;La Fleur, 2006;Spencer & Tilbrook, 2011).…”
Section: Neuropeptidesmentioning
confidence: 99%
“…These conditions include Cushing's syndrome (Bertagna et al 2009, Spencer & Tilbrook 2011), Cushing's disease (Bertagna et al 2009, Spencer & Tilbrook 2011, obesity (Berga et al 1997), metabolic syndrome (Berga et al 1997), functional hypothalamic amenorrhoea (Sapolsky et al 2000), hyperthyroidism (Breen & Karsch 2004), diabetes mellitus type II (Berga et al 1997), hypertension (Berga et al 1997) and major depression (Berga et al 1997).…”
Section: Introductionmentioning
confidence: 99%